Genmab A/S Statistics
Share Statistics
Genmab A/S has 61.47M
shares outstanding. The number of shares has increased by -2.46%
in one year.
| Shares Outstanding | 61.47M |
| Shares Change (YoY) | -2.46% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 73.88K, so 0.12% of the outstanding
shares have been sold short.
| Short Interest | 73.88K |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 211.69 |
Valuation Ratios
The PE ratio is 12.22 and the forward
PE ratio is 1.58.
Genmab A/S's PEG ratio is
0.14.
| PE Ratio | 12.22 |
| Forward PE | 1.58 |
| PS Ratio | 4.45 |
| Forward PS | 0.3 |
| PB Ratio | 2.61 |
| P/FCF Ratio | 12.84 |
| PEG Ratio | 0.14 |
Financial Ratio HistoryEnterprise Valuation
Genmab A/S has an Enterprise Value (EV) of 87.05B.
| EV / Sales | 4.04 |
| EV / EBITDA | 8.98 |
| EV / EBIT | 11.2 |
| EV / FCF | 11.66 |
Financial Position
The company has a current ratio of 5.25,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.25 |
| Quick Ratio | 5.24 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.14 |
| Interest Coverage | 55.86 |
Financial Efficiency
Return on Equity is 21.38% and Return on Invested Capital is 14.13%.
| Return on Equity | 21.38% |
| Return on Assets | 17.12% |
| Return on Invested Capital | 14.13% |
| Revenue Per Employee | $8,159,969.67 |
| Profits Per Employee | $2,973,464.75 |
| Employee Count | 2,638 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 15.89 |
Taxes
| Income Tax | 1.32B |
| Effective Tax Rate | 14.4% |
Stock Price Statistics
The stock price has increased by -22.75% in the
last 52 weeks. The beta is 0.9, so Genmab A/S's
price volatility has been higher than the market average.
| Beta | 0.9 |
| 52-Week Price Change | -22.75% |
| 50-Day Moving Average | 196.42 |
| 200-Day Moving Average | 220.22 |
| Relative Strength Index (RSI) | 58.52 |
| Average Volume (20 Days) | 1,888 |
Income Statement
In the last 12 months, Genmab A/S had revenue of 21.53B
and earned 7.84B
in profits. Earnings per share was 122.21.
| Revenue | 21.53B |
| Gross Profit | 20.54B |
| Operating Income | 6.7B |
| Net Income | 7.84B |
| EBITDA | 9.7B |
| EBIT | 9.28B |
| Earnings Per Share (EPS) | 122.21 |
Full Income StatementBalance Sheet
The company has 9.86B in cash and 1.03B in
debt, giving a net cash position of 8.83B.
| Cash & Cash Equivalents | 9.86B |
| Total Debt | 1.03B |
| Net Cash | 8.83B |
| Retained Earnings | 23.55B |
| Total Assets | 6.59B |
| Working Capital | 3.28B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 7.77B
and capital expenditures -304M, giving a free cash flow of 7.47B.
| Operating Cash Flow | 7.77B |
| Capital Expenditures | -304M |
| Free Cash Flow | 7.47B |
| FCF Per Share | 116.33 |
Full Cash Flow StatementMargins
Gross margin is 95.42%, with operating and profit margins of 31.14% and 36.44%.
| Gross Margin | 95.42% |
| Operating Margin | 31.14% |
| Pretax Margin | 42.57% |
| Profit Margin | 36.44% |
| EBITDA Margin | 45.05% |
| EBIT Margin | 31.14% |
| FCF Margin | 34.69% |
